US 11484531
Methods for treating chronic obstructive pulmonary disease
granted A61KA61K31/135A61K31/444
Quick answer
US patent 11484531 (Methods for treating chronic obstructive pulmonary disease) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/135, A61K31/444, A61K31/4545, A61K31/5386